A just-announced R&D collaboration involving Sernova Corporation (Sernova Corporation Stock Quote, Chart TSXV:SVA) is a solid advance for the … [Read more...] about Sernova Corp has a huge upside, Echelon Wealth says
Life Sciences
Content brought to you by:
The Cantech Letter Life Sciences section is brought to you by Relay Medical Corp. (CSNX:RELA). Relay is in the business of commercializing innovative technologies, protected by issued and pending patents, in the medical diagnostics and research field with an emphasis on In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). Click on the logo for more info...
Antibe Therapeutics has an upside of 352 per cent, Echelon Wealth says
In an update to clients Wednesday, Echelon Wealth Partners analyst Douglas Loe remains bullish on clinical stage drug developer Antibe Therapeutics … [Read more...] about Antibe Therapeutics has an upside of 352 per cent, Echelon Wealth says
ProMetic Life Sciences is not out of the woods yet, Echelon Wealth says
Echelon Wealth Partners analyst Douglas Loe says ProMetic Life Sciences (ProMetic Life Sciences Stock Quote, Chart TSX:PLI) is not out of the woods … [Read more...] about ProMetic Life Sciences is not out of the woods yet, Echelon Wealth says
Aurinia Pharma is undervalued, Mackie Research says
An executive shakeup by drug developer Aurinia Pharmaceuticals (Aurinia Pharmaceuticals Stock Quote, Chart TSX:AUP, NASDAQ:AUPH) gets a thumbs up from … [Read more...] about Aurinia Pharma is undervalued, Mackie Research says
Profound Medical has 400 per cent upside, says Paradigm Capital
Upcoming catalysts are reason to get interested in medical device company Profound Medical (Profound Medical Stock Quote, Chart TSX:PRN), according to … [Read more...] about Profound Medical has 400 per cent upside, says Paradigm Capital
Buy Oncolytics Biotech for a 331 per cent return, Echelon Wealth says
Echelon Wealth Partners analyst Doug Loe thinks cancer biologics company Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart TSX:ONC) is still … [Read more...] about Buy Oncolytics Biotech for a 331 per cent return, Echelon Wealth says
Stay clear of Prometic Life Sciences, this investor says
It looks like fans of Prometic Life Sciences (Prometic Life Sciences Stock Quote, Chart TSX:PLI) are going to have to put aside their affection for … [Read more...] about Stay clear of Prometic Life Sciences, this investor says
Keep Knight Therapeutics management as is, Paradigm Capital says
In the ongoing fight for control of specialty pharma company Knight Therapeutics (Knight Therapeutics Stock Quote, Chart TSX:GUD), analyst Rahul … [Read more...] about Keep Knight Therapeutics management as is, Paradigm Capital says
Profound Medical gets a target raise from Mackie Research
Profound Medical (Profound Medical Stock Quote, Chart TSX:PRN) is getting a huge target raise from Mackie Research analyst André Uddin on the back of … [Read more...] about Profound Medical gets a target raise from Mackie Research
Take a pass on Theratechnologies, Mackie Research says
A weaker than expected quarter gives Mackie Research’s André Uddin no reason to revise his prevailing thoughts about Theratechnologies … [Read more...] about Take a pass on Theratechnologies, Mackie Research says
